
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer nanomedicine: from targeted delivery to combination therapy
Xiaoyang Xu, William Ho, Xueqing Zhang, et al.
Trends in Molecular Medicine (2015) Vol. 21, Iss. 4, pp. 223-232
Open Access | Times Cited: 634
Xiaoyang Xu, William Ho, Xueqing Zhang, et al.
Trends in Molecular Medicine (2015) Vol. 21, Iss. 4, pp. 223-232
Open Access | Times Cited: 634
Showing 1-25 of 634 citing articles:
Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2129
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2129
The evolution of commercial drug delivery technologies
Ava M. Vargason, Aaron C. Anselmo, Samir Mitragotri
Nature Biomedical Engineering (2021) Vol. 5, Iss. 9, pp. 951-967
Open Access | Times Cited: 974
Ava M. Vargason, Aaron C. Anselmo, Samir Mitragotri
Nature Biomedical Engineering (2021) Vol. 5, Iss. 9, pp. 951-967
Open Access | Times Cited: 974
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
Betty Tyler, David Gullotti, Antonella Mangraviti, et al.
Advanced Drug Delivery Reviews (2016) Vol. 107, pp. 163-175
Closed Access | Times Cited: 900
Betty Tyler, David Gullotti, Antonella Mangraviti, et al.
Advanced Drug Delivery Reviews (2016) Vol. 107, pp. 163-175
Closed Access | Times Cited: 900
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Nathan D. Donahue, Handan Acar, Stefan Wilhelm
Advanced Drug Delivery Reviews (2019) Vol. 143, pp. 68-96
Closed Access | Times Cited: 739
Nathan D. Donahue, Handan Acar, Stefan Wilhelm
Advanced Drug Delivery Reviews (2019) Vol. 143, pp. 68-96
Closed Access | Times Cited: 739
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
Pedro Martins, Joaquim Tiago Cardoso Leles de Jesus, Sofia Nascimento dos Santos, et al.
Molecules (2015) Vol. 20, Iss. 9, pp. 16852-16891
Open Access | Times Cited: 601
Pedro Martins, Joaquim Tiago Cardoso Leles de Jesus, Sofia Nascimento dos Santos, et al.
Molecules (2015) Vol. 20, Iss. 9, pp. 16852-16891
Open Access | Times Cited: 601
The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Claudia Corbo, Roberto Molinaro, Alessandro Parodi, et al.
Nanomedicine (2015) Vol. 11, Iss. 1, pp. 81-100
Open Access | Times Cited: 579
Claudia Corbo, Roberto Molinaro, Alessandro Parodi, et al.
Nanomedicine (2015) Vol. 11, Iss. 1, pp. 81-100
Open Access | Times Cited: 579
Recent advances of cocktail chemotherapy by combination drug delivery systems
Quanyin Hu, Wujin Sun, Chao Wang, et al.
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 19-34
Open Access | Times Cited: 558
Quanyin Hu, Wujin Sun, Chao Wang, et al.
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 19-34
Open Access | Times Cited: 558
Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery
Heidi R. Culver, John R. Clegg, Nicholas A. Peppas
Accounts of Chemical Research (2017) Vol. 50, Iss. 2, pp. 170-178
Open Access | Times Cited: 431
Heidi R. Culver, John R. Clegg, Nicholas A. Peppas
Accounts of Chemical Research (2017) Vol. 50, Iss. 2, pp. 170-178
Open Access | Times Cited: 431
Cloaking nanoparticles with protein corona shield for targeted drug delivery
Jun Yong Oh, Han Sol Kim, L. Palanikumar, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 352
Jun Yong Oh, Han Sol Kim, L. Palanikumar, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 352
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan, Marc Madou, Sourav Kalra, et al.
ACS Nano (2020) Vol. 14, Iss. 7, pp. 7760-7782
Open Access | Times Cited: 349
Gaurav Chauhan, Marc Madou, Sourav Kalra, et al.
ACS Nano (2020) Vol. 14, Iss. 7, pp. 7760-7782
Open Access | Times Cited: 349
Multifunctional nanocrystals for cancer therapy: a potential nanocarrier
Emil Joseph, Gautam Singhvi
Elsevier eBooks (2019), pp. 91-116
Closed Access | Times Cited: 320
Emil Joseph, Gautam Singhvi
Elsevier eBooks (2019), pp. 91-116
Closed Access | Times Cited: 320
Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives
Ruixue Zhang, Ho Lun Wong, Hui Xue, et al.
Journal of Controlled Release (2016) Vol. 240, pp. 489-503
Open Access | Times Cited: 315
Ruixue Zhang, Ho Lun Wong, Hui Xue, et al.
Journal of Controlled Release (2016) Vol. 240, pp. 489-503
Open Access | Times Cited: 315
Nanotechnology for Cancer Therapy Based on Chemotherapy
Chenyang Zhao, Rui Cheng, Zhe Yang, et al.
Molecules (2018) Vol. 23, Iss. 4, pp. 826-826
Open Access | Times Cited: 292
Chenyang Zhao, Rui Cheng, Zhe Yang, et al.
Molecules (2018) Vol. 23, Iss. 4, pp. 826-826
Open Access | Times Cited: 292
Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
Sangiliyandi Gurunathan, Min-Hee Kang, Muhammad Qasim, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3264-3264
Open Access | Times Cited: 288
Sangiliyandi Gurunathan, Min-Hee Kang, Muhammad Qasim, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3264-3264
Open Access | Times Cited: 288
Liposome-based drug co-delivery systems in cancer cells
Sepideh Zununi Vahed, Roya Salehi, Soodabeh Davaran, et al.
Materials Science and Engineering C (2016) Vol. 71, pp. 1327-1341
Closed Access | Times Cited: 278
Sepideh Zununi Vahed, Roya Salehi, Soodabeh Davaran, et al.
Materials Science and Engineering C (2016) Vol. 71, pp. 1327-1341
Closed Access | Times Cited: 278
Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems
Masatoshi Maeki, Niko Kimura, Yusuke Sato, et al.
Advanced Drug Delivery Reviews (2018) Vol. 128, pp. 84-100
Open Access | Times Cited: 276
Masatoshi Maeki, Niko Kimura, Yusuke Sato, et al.
Advanced Drug Delivery Reviews (2018) Vol. 128, pp. 84-100
Open Access | Times Cited: 276
RNA interference-based therapy and its delivery systems
Xiuhui Chen, Lingegowda S. Mangala, Cristian Rodriguez‐Aguayo, et al.
Cancer and Metastasis Reviews (2017) Vol. 37, Iss. 1, pp. 107-124
Open Access | Times Cited: 270
Xiuhui Chen, Lingegowda S. Mangala, Cristian Rodriguez‐Aguayo, et al.
Cancer and Metastasis Reviews (2017) Vol. 37, Iss. 1, pp. 107-124
Open Access | Times Cited: 270
RNAi-based therapeutics and tumor targeted delivery in cancer
Göknur Kara, George A. Călin, Bülent Özpolat
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114113-114113
Closed Access | Times Cited: 256
Göknur Kara, George A. Călin, Bülent Özpolat
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114113-114113
Closed Access | Times Cited: 256
Upconversion nanocomposite for programming combination cancer therapy by precise control of microscopic temperature
Xingjun Zhu, Jiachang Li, Xiaochen Qiu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 249
Xingjun Zhu, Jiachang Li, Xiaochen Qiu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 249
Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine
Amanda K. Pearce, Rachel K. O’Reilly
Bioconjugate Chemistry (2019) Vol. 30, Iss. 9, pp. 2300-2311
Closed Access | Times Cited: 216
Amanda K. Pearce, Rachel K. O’Reilly
Bioconjugate Chemistry (2019) Vol. 30, Iss. 9, pp. 2300-2311
Closed Access | Times Cited: 216
Nanomedicines for renal disease: current status and future applications
Nazila Kamaly, John Cijiang He, Dennis A. Ausiello, et al.
Nature Reviews Nephrology (2016) Vol. 12, Iss. 12, pp. 738-753
Open Access | Times Cited: 210
Nazila Kamaly, John Cijiang He, Dennis A. Ausiello, et al.
Nature Reviews Nephrology (2016) Vol. 12, Iss. 12, pp. 738-753
Open Access | Times Cited: 210
Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications
Jalal Mosayebi, Mehdi Kiyasatfar, Sophie Laurent
Advanced Healthcare Materials (2017) Vol. 6, Iss. 23
Closed Access | Times Cited: 208
Jalal Mosayebi, Mehdi Kiyasatfar, Sophie Laurent
Advanced Healthcare Materials (2017) Vol. 6, Iss. 23
Closed Access | Times Cited: 208
Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
William Ho, Mingzhu Gao, Fengqiao Li, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 8
Open Access | Times Cited: 206
William Ho, Mingzhu Gao, Fengqiao Li, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 8
Open Access | Times Cited: 206
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Hannah J. Vaughan, Jordan J. Green, Stephany Y. Tzeng
Advanced Materials (2019) Vol. 32, Iss. 13
Open Access | Times Cited: 197
Hannah J. Vaughan, Jordan J. Green, Stephany Y. Tzeng
Advanced Materials (2019) Vol. 32, Iss. 13
Open Access | Times Cited: 197
Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives
Eunüs S. Ali, Shazid Md. Sharker, Muhammad Torequl Islam, et al.
Seminars in Cancer Biology (2020) Vol. 69, pp. 52-68
Closed Access | Times Cited: 197
Eunüs S. Ali, Shazid Md. Sharker, Muhammad Torequl Islam, et al.
Seminars in Cancer Biology (2020) Vol. 69, pp. 52-68
Closed Access | Times Cited: 197